Peoples Bank (Kansas)’s AbbVie ABBV Stock Holding History

Peoples Bank (Kansas)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$606K	Sell	2,409 -285	-11%	-$61.3K	0.59%	59
2026 Q1	$586K	Sell	2,694 -293	-10%	-$65K	0.59%	59
2025 Q4	$683K	Sell	2,987 -220	-7%	-$50.1K	0.69%	52
2025 Q3	$743K	Sell	3,207 -1,531	-32%	-$312K	0.74%	48
2025 Q2	$879K	Sell	4,738 -7	-0.1%	-$1.3K	0.59%	54
2025 Q1	$994K	Sell	4,745 -185	-4%	-$36K	0.67%	44
2024 Q4	$876K	Sell	4,930 -55	-1%	-$10.1K	0.61%	49
2024 Q3	$984K	Hold	4,985	–	–	0.66%	46
2024 Q2	$855K	Sell	4,985 -25	-0.5%	-$4.14K	0.67%	45
2024 Q1	$912K	Sell	5,010 -15	-0.3%	-$2.58K	0.71%	44
2023 Q4	$779K	Sell	5,025 -440	-8%	-$64.1K	0.62%	49
2023 Q3	$815K	Buy	+5,465	New	+$802K	0.7%	41

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Peoples Bank (Kansas)'s ABBV Position: Q2 2026 in Review

Peoples Bank (Kansas) reduced its AbbVie (ABBV) stake by 11% in Q2 2026, selling an estimated $61.3K and leaving 2,409 shares worth $606K. The position accounts for 0.59% of the portfolio, ranked #59.

Peoples Bank (Kansas) first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. The position peaked at $994K in Q1 2025. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Peoples Bank (Kansas) held 2,409 shares of AbbVie worth $606K as of Q2 2026.
Peoples Bank (Kansas) sold 285 AbbVie shares in Q2 2026, an estimated $61.3K.
AbbVie made up 0.59% of Peoples Bank (Kansas)'s portfolio in Q2 2026, its #59 holding.
Peoples Bank (Kansas) first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
Peoples Bank (Kansas)'s AbbVie position peaked at $994K in Q1 2025.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Peoples Bank (Kansas)'s 13F filing for Q2 2026, filed 10 Jul 2026.